MARAVAI LIFESCIENCES HOLDINGS, INC. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Maravai Lifesciences Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Maravai Lifesciences Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$169M, a 997% decline year-over-year.
  • Maravai Lifesciences Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$205M, a 341% decline year-over-year.
  • Maravai Lifesciences Holdings, Inc. annual Operating Income (Loss) for 2023 was -$31.6M, a 106% decline from 2022.
  • Maravai Lifesciences Holdings, Inc. annual Operating Income (Loss) for 2022 was $574M, a 3.53% increase from 2021.
  • Maravai Lifesciences Holdings, Inc. annual Operating Income (Loss) for 2021 was $555M, a 363% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$31.6M -$606M -106% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $574M +$19.6M +3.53% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $555M +$435M +363% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $120M +$95.9M +400% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $24M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.